PMID- 12603706 OWN - NLM STAT- MEDLINE DCOM- 20030725 LR - 20191106 IS - 0905-6157 (Print) IS - 0905-6157 (Linking) VI - 14 IP - 1 DP - 2003 Feb TI - Study on the Prevention of Allergy in Children in Europe (SPACE): allergic sensitization at 1 year of age in a controlled trial of allergen avoidance from birth. PG - 10-7 AB - Several studies have demonstrated that early intervention may modulate the natural course of atopic disease. The objective of this study was to prevent sensitization to house dust mite and food allergens, as well as development of atopic symptoms, during infancy. To achieve this we employed the combination of an educational package with the use of mite allergen-impermeable mattress encasings. A multi-center European, population-based, randomized controlled study of children at increased atopic risk [study on the prevention of Allergy in Children in Europe (SPACE)] was performed in five countries (Austria, Germany, Greece, Great Britain, Lithuania) and included three cohorts of schoolchildren, toddlers and newborns. We report on the newborn cohort. A total of 696 newborns were included in Austria, Great Britain and Germany. Inclusion criteria were a positive history of parental allergy and a positive skin-prick test or specific immunoglobulin E (IgE) of >or= 1.43 kU/l against at least one out of a panel of common aeroallergens in one or both parents. At 1 year of age the overall sensitization rate against the tested allergens [dust mite allergens: Dermatophagoides pteronyssinus and D. farinae (Der p and Der f, respectively)] and food allergens (egg, milk) in the prophylactic group was 6.21% vs. 10.67% in the control group. The prevalence of sensitization against Der p was 1.86% in the prophylactic group vs. 5% in the control group. In conclusion, we demonstrated, in a group of newborns at risk for atopic diseases, that the sensitization rate to a panel of aero- and food allergens could be effectively decreased through the use of impermeable mattress encasings and the implementation of preventive measures that were easy to perform. FAU - Halmerbauer, Gerhard AU - Halmerbauer G AD - University Children's Hospital, Wahringer Gurtel, Vienna, Austria. FAU - Gartner, Christian AU - Gartner C FAU - Schierl, Michael AU - Schierl M FAU - Arshad, Hassan AU - Arshad H FAU - Dean, Tara AU - Dean T FAU - Koller, Dieter Y AU - Koller DY FAU - Karmaus, Wilfried AU - Karmaus W FAU - Kuehr, Joachim AU - Kuehr J FAU - Forster, Johannes AU - Forster J FAU - Urbanek, Radvan AU - Urbanek R FAU - Frischer, Thomas AU - Frischer T CN - SPACE Collaborative Study Team LA - eng PT - Clinical Trial PT - Comparative Study PT - Journal Article PT - Multicenter Study PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't PL - England TA - Pediatr Allergy Immunol JT - Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology JID - 9106718 RN - 0 (Allergens) RN - 0 (Antigens, Dermatophagoides) SB - IM MH - Allergens/immunology MH - Antigens, Dermatophagoides/immunology MH - Bedding and Linens MH - Cohort Studies MH - Egg Hypersensitivity/epidemiology/immunology/prevention & control MH - Europe/epidemiology MH - Female MH - Follow-Up Studies MH - Humans MH - Hypersensitivity/epidemiology/immunology/*prevention & control MH - Immunization MH - Incidence MH - Infant Welfare MH - Infant, Newborn MH - Male MH - Milk Hypersensitivity/epidemiology/immunology/prevention & control MH - Patient Compliance MH - Prospective Studies MH - Risk Factors MH - Risk Reduction Behavior MH - Surveys and Questionnaires MH - Treatment Outcome EDAT- 2003/02/27 04:00 MHDA- 2003/07/26 05:00 CRDT- 2003/02/27 04:00 PHST- 2003/02/27 04:00 [pubmed] PHST- 2003/07/26 05:00 [medline] PHST- 2003/02/27 04:00 [entrez] AID - 2o069 [pii] AID - 10.1034/j.1399-3038.2003.02069.x [doi] PST - ppublish SO - Pediatr Allergy Immunol. 2003 Feb;14(1):10-7. doi: 10.1034/j.1399-3038.2003.02069.x.